ISSN: 2161-0495
+44 1478 350008
IView Therapeutics (Zhuhai) Co. Ltd., Hengqin, Zhuhai, China
After graduation from Medical School in 1999, I developed an interest in basic biomedical research and went ahead and obtained a Master of Science degree in molecular biology in 2003. I did my first post-doctoral training in cancer biology and clinical oncology between 2003 and 2004 in Peking Union Medical College and Chinese Academy of Medical Sciences, one of the best medical schools in China, focusing on pharmacogenomics of cancer therapy.
Research Article
In vitro Inactivation of SARS-Cov-2 by Povidone-Iodine In situ Gel Forming
Solution
Author(s): Bo Liang*, Xudong Yuan, Gang Wei, Wei Wang, Ming Zhang, Haizhou Peng, Juan C. Hernaiz-Leonardo, Amin Javer, Michelle Mendenhall, Justin Julander, Sammi Huang, Hany Michail, Yong Lu, Qi Zhu and John Baldwin
Background: Povidone Iodine (PVP-I) nasal solutions are effective against the SARS-CoV-2 virus, but are cleared rapidly from the nasal cavity, limiting its use. PVP-I gel forming solutions can circumvent this problem due to their higher viscosity and prolonged clearing time.
Objective: Characterize the in vitro virucidal activity of long-acting PVP-I compositions developed using an in situ gel forming technology against the SARS-CoV-2 virus and test its safety using a rat model.
Methods: We tested different dilutions of the PVP-I gel forming solution– full concentration, 90%, 50%, 28% and 9% of the original formulation concentration – at varying exposure times to assess virucidal activity against SARSCoV- 2 in VERO76 cells infected. Virucidal activity was recorded as the reduction of v.. View More»
DOI:
10.35248/2161-0495.21.s18.002